ACTUATE THERAPEUTICS, INC. Logo

ACTUATE THERAPEUTICS, INC.

Clinical-stage biopharma developing therapies for cancers with high unmet needs.

ACTU | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
1751 RIVER RUN, 76107 FORT WORTH

Description

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing therapies for cancers with high unmet medical needs. The company's lead drug candidate is elraglusib, a novel, first-in-class small molecule inhibitor of glycogen synthase kinase-3 (GSK-3). Elraglusib is being developed for difficult-to-treat cancers, including metastatic pancreatic cancer. Its mechanism of action targets multiple molecular pathways involved in promoting tumor growth and resistance to conventional drugs. Additionally, it functions as a mediator of anti-tumor immunity by inhibiting immune checkpoints and regulating immune cell function. The company's goal is to develop therapies that can slow, stop, or shrink tumors with minimal adverse effects, thereby improving patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all ACTUATE THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACTUATE THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACTUATE THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Designs, develops, and manufactures molecular diagnostic solutions and instruments.
Türkiye
ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Clinical-stage biopharmaceutical company developing therapeutics for CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and provides in-vitro diagnostic (IVD) solutions and instruments.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for acute cannabinoid intoxication.
United States of America
ANEB
AnGes, Inc. Logo
Biopharmaceutical firm developing gene-based and nucleotide-based medicines.
Japan
4563
Anika Therapeutics, Inc. Logo
A global joint preservation company developing solutions for orthopedic care.
United States of America
ANIK
ANIMALCARE GROUP PLC Logo
Develops and commercializes veterinary pharmaceutical products and services globally.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded, generic, and OTC pharmaceutical products.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Clinical-stage biotech developing a cell-protecting biologic for RVO and oncology.
Sweden
ANNX
Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.